November 20, 2018 / 5:06 PM / a month ago

BRIEF-Santhera Enters Into Agreement To Buy Option From Idorsia For Exclusive Sub-License Of First-In-Class Dissociative Steroid Vamorolon

Nov 20 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG :

* SANTHERA ENTERS INTO AGREEMENT TO ACQUIRE OPTION FROM IDORSIA FOR EXCLUSIVE SUB-LICENSE OF FIRST-IN-CLASS DISSOCIATIVE STEROID VAMOROLON

* IDORSIA TO BECOME LARGEST SHAREHOLDER IN SANTHERA WITH A 13.3% EQUITY STAKE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below